The treatment of digital ischemia remains difficult. Sildenafil (Viagra, Pfizer UK), a selective phosphodiesterase inhibitor, increases blood flow and is currently marketed for the treatment of erectile dysfunction. A case of a 57-year-old man with progressive episodic ischemia and pain of the fingertips resulting in finger tip ulceration is presented. After failure of medical and surgical management, a trial of oral sildenafil resulted in marked symptomatic improvement of his bilateral digital ischemia. Review of the literature shows that, particularly in patients with an underlying disease such as scleroderma with a vasospastic component, a marked improvement in digital blood flow may be observed with sildenafil use. Overall, based on a number of case reports and preliminary animal studies in the literature, sildenafil appears to have a growing significance in the treatment of hand ischemia. Similarly, there is evidence that phosphodiesterase 5 inhibitors may be used as an adjunct to improving skin flap survival.
McLaffertyRB, EdwardsJM, TaylorLMJr, PorterJM. Diagnosis and long-term clinical outcome in patients diagnosed with hand ischemia.J Vasc Surg1995; 22: 361-7; discussion 367-9.
2.
CroomKF, CurranMP. Sildenafil: A review of its use in pulmonary arterial hypertension.Drugs2008; 68: 383-97.
3.
Domek-LopacinskaK, StrosznajderJB. The effect of selective inhibition of cyclic GMP hydrolyzing phosphodiesterases 2 and 5 on learning and memory processes and nitric oxide synthase activity in brain during aging.Brain Res2008; 1216: 68-77.
4.
ReneerkensOA, RuttenK, SteinbuschHW, BloklandA, PrickaertsJ. Selective phosphodiesterase inhibitors: A promising target for cognition enhancement.Psychopharmacology (Berl)2009; 202: 419-43.
5.
RuchDS, HoldenM, SmithBP, SmithTL, KomanLA. Periarterial sympathectomy in scleroderma patients: Intermediate-term follow-up.J Hand Surg Am2002; 27: 258-64.
6.
HerrickA. Diagnosis and management of scleroderma peripheral vascular disease.Rheum Dis Clin North Am2008; 34: 89-114;vii.
7.
BogochER, GrossDK. Surgery of the hand in patients with systemic sclerosis: Outcomes and considerations.J Rheumatol2005; 32: 642-8.
8.
KotsisSV, ChungKC. A systematic review of the outcomes of digital sympathectomy for treatment of chronic digital ischemia.J Rheumatol2003; 30: 1788-92.
9.
SharmaR. Novel phosphodiesterase-5 inhibitors: Current indications and future directions.Indian J Med Sci2007; 61: 667-79.
10.
OmoriK, KoteraJ. Overview of PDEs and their regulation.Circ Res2007; 100: 309-27.
11.
SchwarzER, KapurV, RodriguezJ, RastogiS, RosanioS. The effects of chronic phosphodiesterase-5 inhibitor use on different organ systems.Int J Impot Res2007; 19: 139-48.
12.
MironeV, FuscoF, RossiA, SicuteriR, MontorsiF. Tadalafil and vardenafil vs sildenafil: A review of patient-preference studies.BJU Int2009; 103: 1212-7.
KassDA, ChampionHC, BeavoJA. Phosphodiesterase type 5: Expanding roles in cardiovascular regulation.Circ Res2007; 101: 1084-95.
15.
FriesR, ShariatK, von WilmowskyH, BohmM. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.Circulation2005; 112: 2980-5.
16.
SenthilkumarA, SmithRD, KhithaJSildenafil promotes ischemia-induced angiogenesis through a PKG-dependent pathway.Arterioscler Thromb Vasc Biol2007; 27: 1947-54.
17.
KapurV, ChienCV, FuessJE, SchwarzER. The relationship between erectile dysfunction and cardiovascular disease. Part II: The role of PDE-5 inhibition in sexual dysfunction and cardiovascular disease.Rev Cardiovasc Med2008; 9: 187-95.
18.
HeymannWR. Sildenafil for the treatment of Raynaud's phenomenon.J Am Acad Dermatol2006; 55: 501-2.
19.
YungA, ReayN, GoodfieldMD. Improvement in digital flexibility and dexterity following ingestion of sildenafil citrate (viagra) in limited systemic sclerosis.Arch Dermatol2005; 141: 831-3.
20.
ColglazierCL, SutejPG, O'RourkeKS. Severe refractory fingertip ulcerations in a patient with scleroderma: Successful treatment with sildenafil.J Rheumatol2005; 32: 2440-2.
21.
FrancisSH, CorbinJD. Sildenafil: Efficacy, safety, tolerability and mechanism of action in treating erectile dysfunction.Expert Opin Drug Metab Toxicol2005; 1: 283-93.
22.
HayrehSS. Erectile dysfunction drugs and non-arteritic anterior ischemic optic neuropathy: Is there a cause and effect relationship?J Neuroophthalmol2005; 25: 295-8.
23.
LatiesAM. Vision disorders and phosphodiesterase type 5 inhibitors: A review of the evidence to date.Drug Saf2009; 32: 1-18.
24.
KontarasK, VarnavasV, KyriakidesZS. Does sildenafil cause myocardial infarction or sudden cardiac death?Am J Cardiovasc Drugs2008; 8: 1-7.
25.
LevienTL. Phosphodiesterase inhibitors in Raynaud's phenomenon.Ann Pharmacother2006; 40: 1388-93.
26.
KamataY, KamimuraT, IwamotoM, MinotaS. Comparable effects of sildenafil citrate and alprostadil on severe Raynaud's phenomenon in a patient with systemic sclerosis.Clin Exp Dermatol2005; 30: 451.
27.
GoreJ, SilverR. Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis.Ann Rheum Dis2005; 64: 1387.
28.
BaumhaekelM, SchefflerP, BoehmM. Use of tadalafil in a patient with a secondary Raynaud's phenomenon not responding to sildenafil.Microvasc Res2005; 69: 178-9.
29.
KumanaCR, CheungGT, LauCS. Severe digital ischaemia treated with phosphodiesterase inhibitors.Ann Rheum Dis2004; 63: 1522-4.
30.
UlusoyMG, UysalA, KocerUImproved flap viability with site-specific delivery of sildenafil citrate using fibrin glue.Ann Plast Surg2005; 55: 292-6.
31.
SarifakiogluN, GokremS, AtesL, AkbugaUB, AslanG. The influence of sildenafil on random skin flap survival in rats: An experimental study.Br J Plast Surg2004; 57: 769-72.
32.
TsaiJW, AyubiFS, HartKLEvaluation of the effect of sildenafil and vascular endothelium growth factor combination treatment on skin flap survival in rats.Aesthetic Plast Surg2008; 32: 624-31.
33.
HartK, BaurD, HodamJShort- and long-term effects of sildenafil on skin flap survival in rats.Laryngoscop2006; 116: 522-8.
34.
OhM, ChangH, MinnKW. The effects of tadalafil on axial-pattern skin flap survival in rats.Dermatol Surg2008; 34: 626-30; discussion 630.
